307 related articles for article (PubMed ID: 8807721)
1. Current trends in antithrombotic drug and device development.
Fareed J
Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
[TBL] [Abstract][Full Text] [Related]
2. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives in the treatment of thrombotic disorders.
Drouet L; Caen JP
Semin Thromb Hemost; 1989 Apr; 15(2):111-22. PubMed ID: 2665082
[TBL] [Abstract][Full Text] [Related]
5. The future of anticoagulation.
Hoppensteadt DA; Jeske W; Walenga J; Fareed J
Semin Respir Crit Care Med; 2008 Feb; 29(1):90-9. PubMed ID: 18302091
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the new antithrombotic drugs.
Walenga JM; Hoppensteadt DA
Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
8. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
Bick RL; Frenkel EP; Walenga J; Fareed J; Hoppensteadt DA
Hematol Oncol Clin North Am; 2005 Feb; 19(1):1-51, v. PubMed ID: 15639107
[TBL] [Abstract][Full Text] [Related]
9. An update on heparins at the beginning of the new millennium.
Fareed J; Hoppensteadt DA; Bick RL
Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802
[TBL] [Abstract][Full Text] [Related]
10. Management of thrombotic and cardiovascular disorders in the new millenium.
Fareed J; Hoppensteadt DA; Bick RL
Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic and clinical characteristics of thrombolytic agents.
Deitcher SR; Jaff MR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
[TBL] [Abstract][Full Text] [Related]
12. Current trends in the development of anticoagulant and antithrombotic drugs.
Fareed J; Hoppensteadt D; Walenga JM; Bick RL
Med Clin North Am; 1994 May; 78(3):713-31. PubMed ID: 8170266
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
14. [New agents and challenges in the antithrombotic management of arterial diseases].
Udvardy M; Rák K
Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. [Where to look for progress in antithrombotic treatments?].
Samama MM
Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
[TBL] [Abstract][Full Text] [Related]
17. Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation.
Hoppensteadt D; Walenga JM; Fareed J; Bick RL
Hematol Oncol Clin North Am; 2003 Feb; 17(1):313-41. PubMed ID: 12627673
[TBL] [Abstract][Full Text] [Related]
18. [Targets of antithrombotic drugs].
Drouet L; Ripoll L
Med Sci (Paris); 2006 Oct; 22(10):887-94. PubMed ID: 17026945
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and hemostasis.
Grignani G; Maiolo A
Haematologica; 2000 Sep; 85(9):967-72. PubMed ID: 10980636
[TBL] [Abstract][Full Text] [Related]
20. Hirudin as alternative anticoagulant--a historical review.
Markwardt F
Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
